ArticleJournal of clinical microbiology2021
Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant Candida auris Compared with Other Commercially Available Formulations.
Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 60 citations in OpenAlex.
- Candida auris: a multidimensional focus on its identification, epidemiology, pathogenesis, and therapeutic options.Archives of microbiology · 2026Review
- Review
- An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025Review
- Molecular Identification and Phylogenetic Characterization of Yeast Species Isolated from Complete Denture in Sulaymaniyah, Iraq.Polish journal of microbiology · 2025Article
- Expansion of the Candidozyma haemuli Species Complex - The Novel Species Candidozyma molenica, Isolated from Clinical and Environmental Sources.Mycopathologia · 2025Article
- Diagnostic Approaches forMicroorganisms · 2025Review
- Review
- Keep the Hospital Clean: Diagnostic Performance of Ten Different Molecular and Culture-Based Methods to Detect Candidozyma (Candida) auris.Mycopathologia · 2025Article
- Epidemiological Trends and Antimicrobial Resistance ofInfection and drug resistance · 2025Article
- Is routine screening forIranian journal of microbiology · 2024Article
- Validation of a qualitative real-time PCR assay for the detection ofJournal of clinical microbiology · 2024Article
- Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4Open forum infectious diseases · 2024Article
- Article
- Article
- Evaluation of CHROMagarMicrobiology spectrum · 2024Article
- A lateral flow immunoassay for the rapid identification ofFrontiers in microbiology · 2024Article
- Skin and hard surface disinfection againstFrontiers in medicine · 2024Review
- Candida haemulonii complex, an emerging threat from tropical regions?PLoS neglected tropical diseases · 2023Review
- Perspective on the origin, resistance, and spread of the emerging human fungal pathogen Candida auris.PLoS pathogens · 2023Article
- Identification of Pathogenic and Opportunistic Yeasts in Pigeon Excreta by MALDI-TOF Mass Spectrometry and Their Prevalence in Chon Buri Province, Thailand.International journal of environmental research and public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.